跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REBIF 44 interferon beta-1a (rch) 132 microgram/1.5mL solution for injection multidose cartridge - TGA Drug Approval Details
Approvals
/
TGA
/
REBIF 44 interferon beta-1a (rch) 132 microgram/1.5mL solution for injection multidose cartridge
Approved
STANDARD
REBIF 44 interferon beta-1a (rch) 132 microgram/1.5mL solution for injection multidose cartridge
Merck Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
057ad869d3bb0111
Company
Merck Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
057ad869d3bb0111
Product Name
REBIF 44 interferon beta-1a (rch) 132 microgram/1.5mL solution for injection multidose cartridge
Artg Id
165746
Artg Name
REBIF interferon beta-1a (rch) 132 microgram/1.5mL solution for injection multidose cartridge
Sponsor
Merck Healthcare Pty Ltd
Company Detail Path
/organization/merck-healthcare-pty-ltd
Artg Date
2010-01-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
057ad869d3bb0111
Type
Standard
Back to TGA Approvals